Pebblebrook reported $0.32 FFO per diluted share against a $0.23 consensus estimate. That's a 39% beat. Revenue came in at $345.66 million versus the $328.43 million estimate. Same-property hotel EBITDA hit $82.2 million, up 27.6%, exceeding the high end of their own outlook by $8.2 million.

The RevPAR composition is where it gets interesting. Same-property RevPAR grew 11.8% to $215.78. Occupancy drove 550 basis points of that. ADR contributed 2.8%. For a portfolio trading at 5.5x net debt to trailing EBITDA (down from 5.9x at year-end), occupancy-led growth is the better signal... it means the physical demand is real, not just rate inflation on a flat base. But 2.8% ADR growth against a quarter where San Francisco RevPAR jumped 44.5% and Los Angeles jumped 31.5% tells you the rate power is concentrated in two markets with event-driven tailwinds (Super Bowl, a major citywide convention). Strip those out and the ADR story gets quieter.

The expense line is what I'd circle. Same-property total expenses grew 5.6% against 11.8% RevPAR growth. That's a 327 basis point margin expansion. In my audit years, that ratio was the first thing I checked when a management company claimed "operational excellence." Revenue growth is partly luck. Expense discipline at scale is a decision. Pebblebrook's portfolio shift (resort EBITDA contribution up to 45% from 17% pre-transformation) is finally producing the flow-through profile that justifies the five-year repositioning thesis... $802 million in resort acquisitions, $1.2 billion in urban dispositions. The margin tells you whether the strategy is working. This quarter, it's working.

Two caveats. Washington, D.C. posted RevPAR down 24.1%. Boston was down 3%. PEB still carries a net loss of $18.4 million (narrowed from $32.2 million, but still negative on a GAAP basis). And the company spent $11.9 million in Q1 capital improvements against a full-year target of $65 to $75 million, which means the CapEx acceleration is backloaded. The strong Q1 gives management room to maintain guidance rather than raise it... and they chose the cautious path, citing geopolitical and macroeconomic uncertainty. That's telling. A management team sitting on a 39% FFO beat that doesn't raise guidance is pricing in something they're not saying out loud.

The stock closed at $14.32 after a 1.13% after-hours move. Morgan Stanley had a $10 price target on this in April. The stock is now 43% above that target. Someone's model is broken. I'd check the cap rate assumption underlying the bear case, because a portfolio generating $82.2 million in quarterly same-property EBITDA with improving leverage metrics doesn't price like a distressed urban play anymore. The repositioning changed the risk profile. Not every analyst's model has caught up.

Pebblebrook's adjusted FFO guidance for FY26 landed at $1.60-$1.70 per share, clearing the $1.59 consensus by a hair at the midpoint. Q1 adjusted FFO came in at $0.32, roughly 45% above the Street's $0.22 estimate. Adjusted EBITDAre of $73.3 million topped the company's own outlook by $9.3 million. Those are clean beats. The question is what the owner of PEB shares is actually getting for holding this stock at $12.

Let's decompose. Full-year EBITDAre guidance is $336-$348 million at the new midpoint. Net debt to trailing EBITDA sits at 5.5x, down from 5.9x at year-end 2025. That's improvement, but 5.5x is not low leverage for a lodging REIT in a cycle where urban recovery is "positive but muted" (Baird's phrase, and it's generous). Approximately 98% of debt is fixed at 4.1% weighted average, unsecured, with nothing material maturing until 2028. That buys time. Time is not the same as margin of safety.

The capital allocation math is where this gets interesting. Pebblebrook has repurchased 18.8 million shares since October 2022 at an average of $13.34. Current price is roughly $12. That's a portfolio of buybacks underwater by about 10%. The Q1 repurchases (0.4 million shares at $12.11) suggest management believes the stock is cheap relative to NAV. They might be right. But a company paying $0.01 per share quarterly... $0.04 annualized on a $12 stock... is telling you it has better uses for cash than returning it. CapEx guidance is $65-$75 million for the year. The $525 million redevelopment program is substantially complete, which theoretically frees up free cash flow. Theoretically.

The portfolio transformation deserves credit. Resort EBITDA contribution moved from 17% to 45% since 2019. Urban exposure dropped from 83% to 55%. Five acquisitions totaling $802 million in, 15 dispositions totaling $1.2 billion out. That's a real strategic pivot, not a PowerPoint one. The incremental $40-$50 million in annual EBITDA from redevelopments by end of 2026 is the number that matters most for the forward story. If it materializes, the current guidance looks conservative. If urban markets like San Francisco and Los Angeles recover slower than modeled (and I've seen enough "recovery" projections to know the variance band is wide), the midpoint becomes the ceiling.

Analyst sentiment tells its own story. Stifel says buy at $16.25. Barclays says underweight at $9.00. That's a $7.25 spread on a $12 stock. When the Street can't agree within 60% of the share price, nobody has conviction. The Zacks upgrade to strong-buy on April 15 is noise (Zacks upgrades correlate with estimate revisions, not fundamental views). The real signal is in the "Hold" consensus with a $12.42 average target... essentially where the stock already trades. The market is saying: we believe you, but not enough to pay up.

Pebblebrook posted $0.51 FFO per diluted share against a $0.50 consensus estimate, and the stock just hit a 52-week high at $14.33. Revenue came in at $398.7 million, a 1.4% year-over-year decline that missed the Street's $400.6 million target by $1.9 million. Net loss: negative $32.4 million. Same-property RevPAR fell 1.5%, which "outperformed" the estimated decline of 2.3%. Outperforming a negative estimate is still negative.

Let's decompose the capital structure. PEB refinanced $400 million in convertible notes due 2026 into new 1.625% convertibles due 2030, buying them back at a 2% discount to par. That's smart liability management. But there's still $350 million in convertibles maturing December 2026. Net debt to trailing EBITDA sits at 6.1x. For context, most lodging REIT analysts start getting uncomfortable north of 5.0x. PEB's weighted-average interest rate of 4.1% is genuinely low for the sector, but a 6.1x leverage ratio on declining RevPAR is not a comfortable place to build a growth thesis. The $50 million in share repurchases during Q3 signals management believes the stock is cheap... or that organic investment opportunities aren't compelling enough to deploy that capital elsewhere. Both readings are instructive.

The dividend tells you everything the FFO beat doesn't. $0.01 per common share, quarterly. That's $0.04 annualized on a stock trading at $14.33. A 0.28% yield. I audited a management company once where the owner kept asking why the P&L looked healthy but his distributions kept shrinking. The answer was always the same: the operating metrics were fine, but the capital stack was consuming the cash. PEB's $65-75 million annual cap-ex run rate, combined with the remaining $350 million in convertible maturities, explains why a company generating $99.2 million in quarterly adjusted EBITDAre is paying its common shareholders essentially nothing.

The market mix underneath the RevPAR decline matters more than the headline. San Francisco and Chicago showed strength. Los Angeles and D.C. dragged. PEB owns 44 hotels across 13 markets, which means portfolio-level RevPAR obscures property-level dispersion. A portfolio averaging negative 1.5% RevPAR growth could easily contain properties at positive 8% and properties at negative 12%. The Zacks upgrade to "strong-buy" on April 15 presumably reflects the thesis that PEB's $525 million redevelopment program positions the portfolio for rate recovery. That thesis requires RevPAR to inflect positive and stay there long enough to de-lever.

The question I'd ask before the Q1 2026 call on April 28: what does RevPAR look like in the markets where PEB deployed the heaviest redevelopment capital, and has the rate premium materialized relative to comp set? If $525 million in repositioning spend hasn't moved the RevPAR index meaningfully above 100 in those markets, the capital allocation thesis needs revisiting. The stock can hit 52-week highs on sentiment. The owner's return is determined by cash flow after the capital stack takes its share... and right now, that share is substantial.

PEB closed near $14.26 this week against a 200-day moving average of $11.84. That's a 20.4% premium to the trend line. The stock hit a 52-week high of $14.33 on Monday. At a market cap of roughly $1.6 billion, the market is valuing this portfolio at approximately $28.07 million per property across its roughly 57 properties (the math varies depending on which assets you include post-recycling). The Q4 2025 beat was real... $0.27 EPS against a $0.23 consensus, $349 million in revenue against $342 million expected. Those aren't rounding errors. But the 2026 guidance tells the other story: net income between negative $10.4 million and positive $3.6 million. The midpoint is a loss. The stock is at a 52-week high.

Let's decompose what the market is actually buying. Pebblebrook's capital recycling strategy shifted resort EBITDA contribution from 17% to 45% since 2019. That's a real transformation. Management projects $71 million in EBITDA upside from three sources: $45 million from urban recovery (primarily San Francisco), $10 million from redevelopment ROI, and $16 million from full restoration of a hurricane-damaged resort property. The first number is the one I'd stress-test. San Francisco "showing signs of recovery" and San Francisco delivering $45 million in incremental EBITDA are separated by a significant amount of execution risk. I've seen REITs price in urban recovery before. The timeline is almost always longer than the model assumes.

The analyst consensus is telling. Fourteen brokerages cover PEB. Five rate it "Sell." Six rate it "Hold." One says "Buy." Two say "Strong Buy." The average target is $12.42 to $13.27... below where the stock trades today. When the stock is above the average analyst target and the consensus is "Hold," someone is wrong. Either the analysts are behind the move or the market is ahead of itself. The $2.5 billion in total debt with a debt-to-equity ratio that cannot be verified from the given numbers adds another variable. At net debt to adjusted EBITDA that management wants below 6.0x, there's limited margin for a revenue shortfall. If the urban recovery stalls even one quarter, the leverage profile gets uncomfortable fast.

The $0.01 quarterly dividend (0.28% yield) signals something specific. This is a REIT that is retaining virtually all cash flow. That's defensible if the capital recycling and redevelopment pipeline generates the projected returns. It's a warning sign if those returns don't materialize and the stock is priced for a growth story that needs the dividend to stay suppressed. An owner of PEB equity is buying a levered bet on urban hotel recovery with almost no current income. That's a trade, not a yield investment.

The 200-day moving average breakout is a technical event. Technicals matter because money flows to them. But the fundamentals underneath are a company guiding to a possible net loss while its stock hits 52-week highs. That spread between market sentiment and operating reality is where the risk lives. Q1 2026 results drop April 28. If RevPAR growth comes in below the 2.25% low end of guidance, the gap between the stock price and the operating story closes fast... and not in the direction equity holders want.

Pebblebrook reported $1.58 in Adjusted FFO per diluted share for 2025, $0.05 above the midpoint of its own outlook. Same-Property Hotel EBITDA came in at $348.2 million, $2.2 million above guidance. The stock price tells you the market doesn't care. PEB has been trading around $11 for months. The company repurchased 6.3 million shares at an average of $11.37. Management says that's an attractive discount to NAV. The question is whether management is right about the NAV.

Let's decompose what happened. The net loss of $62.2 million includes $48.9 million in impairment charges from hotel dispositions. That's not operational failure. That's the accounting reality of selling hotels below their book value. Pebblebrook generated $116.3 million in disposition proceeds in Q4 alone and used $100 million of that to pay down debt. They also closed a new $450 million unsecured term loan maturing in 2031, replacing a $360 million facility due in 2027. The balance sheet is getting cleaner. But cleaner isn't the same as stronger (my parents ran a small business... I learned early that paying off one bill by selling the furniture works exactly once).

The 2026 guidance is where it gets interesting. Adjusted FFO per share of $1.50 to $1.62. The midpoint is $1.56. That's lower than 2025's $1.58. Same-Property Total RevPAR growth of 2.25% to 4.25%. Adjusted EBITDAre of $325 to $339 million, down from $342.5 million in 2025. Net income range of negative $10.4 million to positive $3.6 million. Management is guiding to lower EBITDA year-over-year while projecting RevPAR growth. That gap needs explaining. Part of it is the reduced portfolio from dispositions. Part of it is $65 to $75 million in capital investments. But the flow-through question remains: if RevPAR grows 3% and EBITDA shrinks, where is the money going?

Q4 2025 offers a clue. Same-Property Total RevPAR grew 2.9%, driven by occupancy gains and 5.5% growth in out-of-room revenues. The out-of-room number is the one I'd watch. Pebblebrook has been repositioning toward urban and resort lifestyle assets with higher ancillary revenue potential. That strategy works when you can staff F&B outlets and programming. It breaks when labor costs eat the incremental revenue. The 35% jump in Q4 Adjusted FFO per share looks impressive until you realize it's partly a function of a smaller share count from buybacks, not just operational improvement. Buybacks at a discount to NAV can be accretive. Buybacks that mask flat operating performance are a different story.

The real number here is the implied cap rate on recent dispositions. $116.3 million in Q4 proceeds across two hotels. Without per-property detail, I can't decompose precisely, but Pebblebrook has been selling assets in markets they're exiting (West Coast urban, primarily) at prices that generated impairment charges. That means they're selling below book. They're calling it portfolio optimization. An owner I talked to once put it differently: "I'm making money for everyone except myself." The management company collects fees on the way up and the way down. The REIT investor absorbs the write-down. If you own PEB, the question isn't whether the strategy is directionally correct. It probably is. The question is whether you'll still own it long enough for the repositioned portfolio to deliver.

$72 million for 752 keys on Michigan Avenue. That's $95,745 per key on a hotel Pebblebrook acquired for $156 million in 2018 (which itself was a discount from the $215 million paid in 2006). Trailing twelve-month EBITDA: $4.6 million. NOI after a 4% reserve: $2.5 million. The stated cap rate on trailing NOI is 3.5%. Let's decompose that.

A 3.5% cap rate on $2.5 million NOI doesn't mean the buyer thinks this is a 3.5% return asset. It means the buyer is pricing the hotel on future NOI, not trailing. The PIP hasn't been done. The capital expenditure profile is substantial (Pebblebrook's CEO noted replacement cost of roughly $600,000 per key... $451 million for context). The buyer, Ketu Amin's Vinayaka Hospitality, is betting that post-renovation cash flow justifies the basis. At $96K per key, the margin for error is wide. That's the thesis. Buy at a fraction of replacement cost, execute the PIP, stabilize at a meaningfully higher NOI, and own a 752-room full-service asset on Michigan Avenue for less than a select-service costs to build in most secondary markets.

The seller's math is different and equally rational. Pebblebrook used the $72 million (alongside $44.25 million from the Montrose at Beverly Hills sale) to pay down $100 million in debt. CEO Jon Bortz has been explicit: the company's stock trades at roughly 50% of net asset value, so every dollar of sale proceeds redeployed into share repurchases is, by his math, buying real estate at half price through the public market. Pebblebrook isn't selling because it's distressed. It's selling because it believes its own stock is cheaper than its own hotels. That's a capital allocation decision, not a fire sale... though the per-key number makes it look like one.

The number that should get attention from anyone holding urban full-service assets: $96K per key for a branded, 752-room hotel on one of the most recognized commercial corridors in the country. This is not a secondary-market select-service. This is Michigan Avenue. And it traded at a price that would have been unremarkable for a 120-key Courtyard in a tertiary market five years ago. The delta between that $96K and the $600K replacement cost tells you two things simultaneously. First, the current income stream does not support the physical asset's theoretical value. Second, someone with capital and conviction can acquire irreplaceable locations at a basis that hasn't existed in a generation. Both of those things are true at the same time.

Pebblebrook's broader posture reinforces the pattern. Same-property EBITDA grew 3.9% in Q4 2025. The company refinanced into a $450 million unsecured term loan due 2031. It's forecasting 2.25% to 4.25% same-property RevPAR growth for 2026. This is not a distressed seller dumping assets. This is a REIT that looked at the capital required to reposition a 752-key urban full-service hotel, compared it to the return on buying its own shares at a 50% NAV discount, and chose the shares. That choice tells you everything about where public-market hotel investors see risk-adjusted returns right now... and it's not in high-capex urban repositioning.

I have sat through more REIT earnings presentations than I care to count, and I can tell you exactly when the word "confident" shows up in a press release... it shows up when the numbers need a narrative assist. Pebblebrook posted a full-year net loss of $62.2 million in 2025, including nearly $49 million in impairment charges from hotel dispositions, and their 2026 outlook ranges from a $10.4 million loss to a $3.6 million gain. That is not confidence. That is a coin flip dressed in a blazer.

Now, here's where it gets interesting, because the Q4 story is legitimately compelling. Same-property RevPAR up 2.9%, hotel EBITDA up 3.9% to $64.6 million, and San Francisco... San Francisco came back swinging with total RevPAR up over 32% in Q4 and hotel EBITDA growth of 58.5% for the full year. If you're an owner or asset manager looking at urban upper-upscale exposure, that San Francisco number should make you sit up. Boston, Chicago, Portland showed life too. But here's the thing I keep coming back to... one recovering market does not make a portfolio thesis. LA got hit by wildfires. D.C. demand softened with government disruption. San Diego underperformed. When your "confidence" rests on the assumption that your best-performing market will keep accelerating while your problem markets stabilize simultaneously, you're not forecasting. You're hoping. And hope, as my dad used to say, is not a line item.

The capital story is where I actually see smart execution. They sold two hotels in Q4 for $116.3 million, used $100 million of that to pay down debt, refinanced a $360 million term loan into a new $450 million facility pushed out to 2031, and paid off the mortgage on one of their resort properties. Weighted-average interest rate of 4.1% with 3.1 years of average maturity. That's disciplined. That's someone who remembers what happens when the cycle turns and your debt stack is a mess. They also bought back 6.3 million shares at an average of $11.37 with the stock now around $12.43... so the buyback math looks decent on paper. The question is whether that capital would have been better deployed into the properties themselves. Their $525 million redevelopment program is "largely complete," and they're guiding $65-75 million in CapEx for 2026, which is a meaningful step-down. That's either a sign of a mature portfolio entering harvest mode, or it's a sign that the balance sheet can't support both buybacks AND the investment the assets need. I've watched enough REITs make that trade-off to know which one it usually is (and it's usually the one that shows up in deferred maintenance three years later).

The analyst community is telling you everything you need to know with their consensus "Hold" rating. Wells Fargo just dropped their target to $12 on the same day Kalkine ran this "navigates confidently" headline. Cantor Fitzgerald went to $14. That's a $2 spread on a $12 stock, which means the people paid to evaluate this company can't agree on whether it's worth 3% less or 13% more than where it trades today. When I was brand-side, I learned to pay close attention to the gap between what a company says about itself and what the market says back. A 7% pop after earnings is nice. But the stock is at $12.43 after a year where same-property EBITDA was $348 million across 44 upper-upscale and luxury hotels... that's roughly $7.9 million per property. For the quality of assets Pebblebrook claims to own, in the markets they claim are recovering, you'd expect the market to be more enthusiastic. It's not. And the market usually knows something.

The real story here isn't whether Pebblebrook is "confident." Of course they're confident... that's what you say on an earnings call. The real story is the math underneath the confidence. A 2026 FFO guide of $1.50-$1.62 per share, against a share price of $12.43, puts you at roughly an 8x multiple on the midpoint. That's the market saying "I believe your current earnings but I don't believe your growth story." And for owners in similar urban upper-upscale positions who are looking at Pebblebrook as a comp for their own recovery timeline... that skepticism from the capital markets should be instructive. San Francisco's recovery is real. But building a portfolio narrative on one market's momentum while half your other markets face structural headwinds is exactly the kind of optimism I've learned (the hard way) to interrogate before I celebrate.

Pebblebrook closed 2025 with $1.48 billion in revenue, AFFO of $1.58 per diluted share (beating outlook by $0.05), and same-property RevPAR growth of 2.9% in Q4. The headline numbers look like a company moving in the right direction. The stock price says the market doesn't believe the trajectory holds. Shares trading near $12 against a stated NAV of $23.50 is a 49% discount. That's not a rounding error. That's the market pricing in structural doubt about the durability of urban upper-upscale recovery.

Let's decompose what "rebound and reset" actually means here. San Francisco delivered 37.9% RevPAR growth in Q4 and a 58.5% Hotel EBITDA increase for full-year 2025. Impressive until you remember the denominator. San Francisco was the worst-performing major hotel market in the country for three consecutive years. A 58% gain on a deeply depressed base still leaves you short of 2019 economics in most cases. The portfolio shift tells the real story: San Francisco went from the company's largest market to 7% of Hotel EBITDA, while San Diego climbed to 23% and resorts now generate 48% of EBITDA (up from 17% in 2019). Pebblebrook didn't just wait for urban to come back. They repositioned around the possibility that it wouldn't come back fast enough.

The capital structure is cleaner than it was. A new $450 million term loan due 2031 replaced the $360 million 2027 maturity, and 98% of debt is effectively fixed at a weighted average of 4.1%. That's competent treasury management. The $71.3 million in share repurchases at $11.37 average makes mathematical sense when you believe your NAV... you're buying $23.50 of assets for $11.37. But the 2026 guidance still includes a scenario where net income is negative ($10.4 million loss at the low end). A company buying back stock while guiding toward potential losses is making a bet that the market is wrong about them. Sometimes that bet pays off. Sometimes the market is right.

The 2026 outlook calls for 2.25% to 4.25% same-property RevPAR growth and Adjusted FFO of $1.50 to $1.62 per share. At midpoint, that's roughly flat to 2025. The $65 to $75 million CapEx budget is slightly below 2025's $74.6 million, which makes sense given the $525 million redevelopment program is substantially complete. The question for anyone holding similar upper-upscale urban assets: what happens when the renovation lift is fully absorbed and you're competing on operations alone? The easy gains from repositioning are behind this portfolio. The next dollar of NOI growth has to come from rate power, occupancy, and expense discipline. That's harder.

CEO Bortz buying 15,000 shares in early March is a signal worth tracking, not overweighting. Insider purchases in a REIT trading at half NAV are practically obligatory from an optics standpoint. The Zacks upgrade from "strong sell" to "hold" is similarly modest... "hold" is not conviction. The real tell is flow-through. Pebblebrook grew Q4 same-property Hotel EBITDA 3.9% on 2.9% RevPAR growth. That's decent but not exceptional margin expansion. For a portfolio that just completed half a billion dollars in renovations, I'd want to see that spread widen. If it doesn't, the redevelopment thesis starts to compress.

Pebblebrook's Q1 2026 same-property hotel EBITDA guidance sits at $70M-$74M. That's the number. Not the RevPAR growth range (7.5%-9.0%), which is what management wants you to focus on. The EBITDA range is what tells you whether revenue is actually flowing to the bottom line or getting absorbed by labor and operating costs on the way down.

Full-year 2025: $1.48 billion in revenue, negative $65.8 million net income. The 2026 outlook brackets somewhere between losing another $10.4 million and earning $3.6 million. That's a $14 million swing and the midpoint is roughly breakeven. For a 44-property, 11,000-room portfolio concentrated in urban and resort markets, breakeven after a year and a half of "recovery" tells you something about the cost structure. Adjusted FFO per diluted share was $1.58 for 2025. Stock trades around $12. You're paying roughly 7.6x trailing FFO for a portfolio that hasn't produced positive net income yet. That's either a deep value play or a trap, and the Q1 call is where we start to find out which.

The balance sheet moves are worth decomposing. $450 million unsecured term loan closed in February, maturing 2031. $650 million revolver extended to October 2029. Two hotel sales in Q4 for $116.3 million, $100 million of which went straight to debt reduction. Management is clearly de-risking the capital structure, which is smart... but selling assets to pay down debt while your stock trades at roughly 50% of NAV (Palogic's estimate, and they're not wrong) means you're liquidating at a discount to fund solvency. An owner I worked with once described this exact dynamic: "I'm selling dollars for fifty cents to keep the lights on." He wasn't wrong either.

The San Francisco story is the one analysts keep pointing to. Truist called it "potentially one of the best storylines" in lodging REIT coverage for 2026. Fine. But "best storyline" and "best returns" aren't the same thing. Pebblebrook has heavy exposure to SF, and the easy comps from 2024-2025 will flatter year-over-year numbers. The question is whether the absolute RevPAR levels in those urban markets generate enough contribution after brand costs, labor, and deferred maintenance to justify the capital tied up in these assets. RevPAR growth on a depressed base is math, not recovery.

Thirteen analysts cover this stock. Six say sell. Five say hold. One buy. One strong buy. That distribution tells you the consensus view: the portfolio is real, the assets are good, but the path to consistent positive net income is still unclear. If Q1 EBITDA comes in at the low end of the $70M-$74M range, expect the NAV discount conversation to intensify. If it comes in above $74M, management buys another quarter of credibility. Either way, the number to watch isn't RevPAR. It's flow-through.

Pebblebrook is trading at roughly $11.75 per share against a stated NAV of $23.50. That's a 50% discount. Let's decompose that, because a gap this wide is either an opportunity or a confession.

The Q4 2025 numbers aren't terrible. Same-property EBITDA grew 3.9% to $64.6 million. Total RevPAR climbed 2.9%, with out-of-room revenue up 5.5% (that's the resort repositioning showing up in the actuals). Adjusted FFO per diluted share hit $0.27 for the quarter, a 35% jump year-over-year, though share buybacks did some of the lifting there. Full-year adjusted FFO was $1.58 per share. The 2026 guide puts that at $1.50 to $1.62, which is essentially flat. Net income guidance ranges from a $10.4 million loss to a $3.6 million gain. Not exactly a victory lap.

Here's where it gets interesting. Since October 2022, Pebblebrook has repurchased nearly 18.5 million shares (roughly 14% of outstanding) at an average of $13.37. They're buying back stock at what they believe is a 43% discount to intrinsic value. They sold two hotels in Q4 for $116.3 million and used $100 million to pay down debt. The new $450 million unsecured term loan pushes maturities to 2031, gets 89% of debt effectively fixed at 4.4%, and moves 98% to unsecured. Net debt to trailing EBITDA is 5.9x. That's not low... but it's manageable, and it's moving in the right direction. The portfolio shift tells the real story: resort assets now generate 48% of hotel EBITDA versus 17% in 2019. East Coast exposure went from 38% to 56%. They've been quietly rebuilding the portfolio while the stock price has done nothing.

So why the discount? The market sees 44 upper-upscale urban and resort hotels and prices in the risk that urban hasn't fully recovered (it hasn't), that the net loss persists (it might), and that 5.9x leverage leaves limited margin for error if RevPAR growth stalls. Analyst consensus is "hold" with a $12-ish price target. The Street is essentially saying: we believe you're worth about what you're trading at. Pebblebrook is saying: we're worth double. Somebody is very wrong. I've audited enough hotel REITs to know that NAV estimates are only as good as the cap rate assumptions underneath them. A 50-basis-point swing in your cap rate assumption can move NAV per share by $3-4. The company says $23.50. The market says $12. That's not a rounding error... that's a fundamental disagreement about what these assets are worth in a private transaction.

The 2026 guide is the tell. Same-property total RevPAR growth of 2.25% to 4.25% on $65-75 million in capital spend. They're past the heavy renovation cycle, which should improve free cash flow. But "should" is doing a lot of work in that sentence. If you own PEB, you're betting that urban recovery continues, that the resort pivot keeps generating above-portfolio returns, and that the public-private valuation gap eventually closes through either stock appreciation or asset sales at private-market pricing. If you're an asset manager evaluating hotel REIT exposure right now, run the numbers at both ends of that guidance range. The spread between the bull case and the bear case here is wider than I've seen for a company this size in years.